<DOC>
	<DOCNO>NCT01718522</DOCNO>
	<brief_summary>The purpose registry collect real life data Sensor Augmented pump therapy usage type 1 DM patient treat Medtronic Insulin pump countinuous glucose monitor system Germany .</brief_summary>
	<brief_title>RANSuP Registerstudie</brief_title>
	<detailed_description />
	<criteria>patient sign informed consent Type 1 DM insulin pump therapy least 3 month prior signature inform consent patient use CGM component part part CSII therapy minimum 1 month participation trial disease drug treatment interfere outcome sensor usage use CGM CSII &lt; 3 days/week patient willing sign inform consent abuse alcohol drug ( exception nicotine consumption ) eat disorder , anorexia , bulimia mental disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>